Hemodialysis Facility-Based Quality-of-Care Indicators and Facility-Specific Patient Outcomes

American Journal of Kidney Diseases

Volumn 54, Issue 3, 2009, Pages 490-497

  Lacson Jr , Eduardo ^a   Wang, Weiling ^a   Lazarus, J Michael ^a   Hakim, Raymond M ^a  

^a FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

Author keywords

clinical epidemiology; clinical performance measures; clinical practice guidelines; end stage renal disease (ESRD); Hemodialysis; hospitalization; mortality risk; outcomes; quality improvement

Indexed keywords

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL;

ADULT; AGED; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENT CLINICS, HOSPITAL; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; RENAL DIALYSIS;

EID: 68849120960     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.01.260     Document Type: Article

References (23)

1. Eknoyan G., Levin N.W., and Steinberg E. The National Kidney Foundation Dialysis Outcomes Quality Initiative. Curr Opin Nephrol Hypertens 6 (1997) 520-523
2. McClellan W.M., Frankenfield D.L., Frederick P.R., Helgerson S.D., Wish J.B., and Sugarman J.R. Improving the care of ESRD patients: A success story. Health Care Financ Rev 24 (2003) 89-100
3. Port F.K., Pisoni R.L., Bragg-Gresham J.L., et al. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif 22 (2004) 175-180
4. Rocco M.V., Frankenfield D.L., Hopson S.D., and McClellan W.M. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 145 (2006) 512-519
5. Plantinga L.C., Fink N.E., Jaar B.G., et al. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: A prospective cohort study. BMC Health Serv Res 7 (2007) 5
6. Tentori F., Hunt W.C., Rohrscheib M., et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?. J Am Soc Nephrol 18 (2007) 2377-2384
7. Frederick P.R., Maxey N.L., Clauser S.B., and Sugarman J.R. Developing dialysis facility-specific performance measures for public reporting. Health Care Financ Rev 23 (2002) 37-50
8. Lowrie E.G., Teng M., Lacson E., Lew N., Lazarus J.M., and Owen W.F. Association between prevalent care process measures and facility-specific mortality rates. Kidney Int 60 (2001) 1917-1929
9. Lowrie E.G., Teng M., Lew N., Lacson Jr. E., Lazarus J.M., and Owen Jr. W.F. Toward a continuous quality improvement paradigm for hemodialysis providers with preliminary suggestions for clinical practice monitoring and measurement. Hemodial Int 7 (2003) 28-51
10. Li Z., Lacson Jr. E., Lowrie E.G., et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48 (2006) 606-615
11. Lacson Jr. E., and Lazarus J.M. The association between blood pressure and mortality in ESRD-Not different from the general population?. Semin Dial 20 (2007) 510-517
12. Lacson Jr. E., Teng M., Lazarus J.M., Lew N., Lowrie E., and Owen W. Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis. Am J Kidney Dis 37 (2001) 267-275
13. Lacson Jr. E., Wang W., Hakim R.M., Teng M., and Lazarus J.M. Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access. Am J Kidney Dis 53 (2009) 79-90
14. Unruh M.L., Evans I.V., Fink N.E., Powe N.R., and Meyer K.B. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis 46 (2005) 1107-1116
15. Karamanidou C., Clatworthy J., Weinman J., and Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol 9 (2008) 2
16. Leggat Jr. J.E., Orzol S.M., Hulbert-Shearon T.E., et al. Noncompliance in hemodialysis: Predictors and survival analysis. Am J Kidney Dis 32 (1998) 139-145
17. Goodkin D.A., Bragg-Gresham J.L., Koenig K.G., et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14 (2003) 3270-3277
18. van Manen J.G., van Dijk P.C., Stel V.S., et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 22 (2007) 187-195
19. Kaysen G.A., Chertow G.M., Adhikarla R., Young B., Ronco C., and Levin N.W. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60 (2001) 333-340
20. Caglar K., Fedje L., Dimmitt R., Hakim R.M., Shyr Y., and Ikizler T.A. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 62 (2002) 1054-1059
21. Stratton R.J., Bircher G., Fouque D., et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: A systematic review and meta-analysis. Am J Kidney Dis 46 (2005) 387-405
22. Kalantar-Zadeh K., Braglia A., Chow J., et al. An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: A pilot/feasibility study. J Ren Nutr 15 (2005) 318-331
23. Leon J.B., Albert J.M., Gilchrist G., et al. Improving albumin levels among hemodialysis patients: A community-based randomized controlled trial. Am J Kidney Dis 48 (2006) 28-36